Factors associated with health-related quality of life, hip function, and health utility after operative management of femoral neck fractures by Sprague, S. (S.) et al.
Factors associated with health-related quality of life, hip function, and health utility after 
operative management of femoral neck fractures 
 
S. Sprague, M. Bhandari, M. J. Heetveld, S. Liew, T. Scott, S. Bzovsky, D. Heels-Ansdell, Q. 
Zhou, M. Swiontkowski, E. H. Schemitsch 
On behalf of the FAITH Investigators (see supplementary material for a full list) 
 
 
 
Abstract 
Aims 
The primary aim of this prognostic study was to identify baseline factors associated with 
physical health-related quality of life (HRQL) in patients after a femoral neck fracture. The 
secondary aims were to identify baseline factors associated with mental HRQL, hip function, and 
health utility. 
Patients and Methods 
Patients who were enrolled in the Fixation using Alternative Implants for the Treatment of Hip 
Fractures (FAITH) trial completed the 12-item Short Form Health Survey (SF-12), Western 
Ontario and McMaster Universities Arthritis Index, and EuroQol 5-Dimension at regular 
intervals for 24 months. We conducted multilevel mixed models to identify factors potentially 
associated with HRQL. 
Results 
The following were associated with lower physical HRQL: older age (-1.42 for every ten-year 
increase, 95% confidence interval (CI) -2.17 to -0.67, p < 0.001); female gender (-1.52, 95% CI - 
3.00 to -0.05, p = 0.04); higher body mass index (-0.69 for every five-point increase, 95% CI - 
1.36 to -0.02, p = 0.04); American Society of Anesthesiologists class III (versus class I) (-3.19, 
95% CI -5.73 to -0.66, p = 0.01); and sustaining a displaced fracture (-2.18, 95% CI -3.88 to -
0.49, p = 0.01). Additional factors were associated with mental HRQL, hip function, and health 
utility. 
Conclusion 
We identified several baseline factors associated with lower HRQL, hip function, and utility after 
a femoral neck fracture. These findings may be used by clinicians to inform treatment and 
outcomes. 
 
Introduction 
Intracapsular fractures of the femoral neck (basal, mid-cervical, and subcapital fracture lines) are 
common and account for approximately 50% of all fractures involving the hip.1 Internal fixation 
is the preferred treatment for patients with an undisplaced fracture and may also be used to treat 
those with a displaced fracture, depending on the characteristics of the patient and the preference 
of the surgeon.2,3 While fixation preserves the hip joint, patients treated in this way are at risk of 
complications such as avascular necrosis, nonunion, implant failure, infection, and shortening at 
the site of the fracture.4-6 These complications may require additional surgery and result in 
diminished health-related quality of life (HRQL) and function.4,7-9 Previous studies have 
examined factors associated with HRQL and function after a fracture of the hip,9-12 with two 
studies looking at this specifically in elderly patients who have sustained a femoral neck fracture 
treated by fixation.13,14 These studies reported that HRQL and health utility, as measured by the 
EuroQol (EQ)-5D,15 were significantly lower in those who suffered a complication, those with 
comorbidities affecting rehabilitation, and those with a displaced fracture. However, both studies 
were conducted using the same cohort of patients, which included only 90 patients and 
consequently could not examine all relevant factors. Identifying additional factors associated 
with reductions in HRQL, function, and health utility may help to optimize the care of these 
patients. 
The recently completed Fixation using Alternative Implants for the Treatment of Hip Fractures 
(FAITH) trial was a multicentre, randomized controlled trial comparing two methods of fixation, 
cancellous screws versus sliding hip screw (SHS) in patients with a femoral neck fracture.4 
Using data from this trial, our aim in this prognostic study was to determine which baseline 
factors are associated with HRQL, the function of the hip, and health utility in patients after a 
femoral neck fracture treated with fixation. 
 
Patients and Methods 
The FAITH trial. Patients aged > 50 years with a low-energy femoral neck fracture (basal, mid-
cervical, or subcapital fracture lines) were eligible for inclusion in the FAITH trial. The protocol 
and results have been published.4,16 The trial was approved by the ethics board of McMaster 
University (REB# 06-402) and by the ethics board at each participating clinical site. The study is 
registered at www.clinicaltrials.gov (identifier: NCT00761813). 
Health-related quality of life. The FAITH trial included HRQL, hip function, and health utility as 
secondary outcomes for a subset of patients collected between March 2008 and March 2014. 
HRQL was measured using the 12-item Short Form Health Survey (SF-12), which involves an 
eight-domain profile of function and wellbeing and physical and mental health summary 
measures.17 Each domain was scored separately from 0 (lowest) to 100 (highest) using 
standardized methods to calculate a physical and mental component score (PCS and MCS). The 
minimally important difference (MID) for the SF-12 is five.17 Hip function was measured using 
the Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire,18 
which includes 24 items to assess pain, stiffness, and function in patients with osteoarthritis of 
the hip or knee. Scores range from 0 to 100, with higher scores indicating worse pain, stiffness, 
and limitations of function. Previous research has reported a MID for global WOMAC score of 
1.29 for worsening and 0.67 for improvement.19 Health utility was measured using the EQ-5D 
questionnaire,15 which is a standardized five-item instrument measuring health status. Scores 
range from 0 to 1, with lower scores indicating worse utility. Previous research has reported a 
MID of 0.074 for the EQ-5D.20 All questionnaires were administered by research personnel at 
baseline, recording the recollection of the prefracture status, and at one week, ten weeks, and six, 
nine, 12, 18, and 24 months postoperatively. 
Selection of baseline factors. We selected baseline factors a priori based on biological rationale 
and previous reports in the literature. Specifically, a systematic review of studies investigating 
HRQL and health status following fractures of the hip found that the mental state, prefracture 
functioning on physical and psychosocial domains, comorbidity, female gender, nutritional 
status, postoperative pain, length of stay in hospital, and complications were factors associated 
with HRQL or health status.9 Another study reported associations between health utility and 
pain, mobility, independence in activities of daily living, and independent living situation for 
patients with a fracture of the hip treated by fixation.13 Finally, one study reported an 
association between the displacement of the fracture and health utility in patients with a fracture 
of the hip treated by fixation.14 Based on these findings and data collected in the FAITH trial, 
we selected the following additional variables for inclusion in our model: baseline HRQL, hip 
function, health utility scores, prefracture living setting and functional status, American Society 
of Anesthesiologists (ASA) classification,21 body mass index (BMI), diabetic status, and gender. 
Additionally, we included an interaction term between randomized treatment (cancellous screws 
or SHS) and smoking status. We included this term because the FAITH trial found three 
subgroup variables that were significant for the primary outcome of revision surgery within 24 
months (displacement, the level of the fracture line, and smoking status). However, when all 
three were entered into a single model, only smoking status remained significant.4 The quality of 
reduction was not included in the models as a surgical characteristic, as less than 0.5% of 
patients in the FAITH trial were deemed to have an unacceptable quality of reduction by the 
Central Adjudication Committee.4 Finally, all models were adjusted for respective baseline 
HRQL, hip function, and health utility scores. For each potential factor, we proposed a priori a 
hypothesized effect for all four dependent variables (i.e. SF-12 PCS, SF-12 MCS, WOMAC 
score, and EQ-5D score). In order to avoid an overfitted or unstable model, there should be at 
least ten times the number of observations as there are factors in a linear regression multilevel 
mixed model.22 Given that there were at least 563 patients in each model, up to 56 factors could 
be included without overfitting. We classified all baseline factors into one of three groups 
(characteristics of the patients, of the fracture, or of the operation). 
Definition of baseline factors. Characteristics of the patients: We analyzed age and BMI as 
continuous variables. We analyzed all other baseline characteristic variables categorically (i.e. 
gender (male vs female), ASA classification (i.e. class I vs class II vs class III vs class IV vs 
class V), prefracture living setting (i.e. institutionalized vs not institutionalized), prefracture 
functional status (using walking aids vs walking independently), smoking status (current smoker 
vs not current smoker), and diabetic status (diabetic vs not diabetic)). 
Characteristics of the fracture: We analyzed all the variables categorically (i.e. displacement 
(undisplaced vs displaced), level of the fracture (i.e. subcapital vs midcervical vs basal), and 
Pauwels classification (type I vs type II vs type III)).23,24 
Characteristics of the operation: We analyzed time from injury to surgery as a continuous 
variable. All other variables were analyzed categorically (i.e. type of reduction (none vs closed 
vs open), quality of placement of the fixation device (acceptable vs unacceptable) and 
randomized treatment group (cancellous screws vs SHS)). 
Statistical analysis. Our statistical analysis plan was determined a priori. We included FAITH 
trial patients with complete data for all factors and respective baseline HRQL, hip function, and 
health utility measures in each model. Those who withdrew early from the trial (e.g. due to death 
or loss to follow-up) were included in the analysis as long as complete data were available for all 
variables. We used descriptive statistics to summarize all factors (frequencies and percentages 
for categorical variables, and means and ranges for continuous variables). Before entering the 
factors into the multivariable models, we calculated all pairwise correlations or associations 
between variables. We calculated correlations between continuous variables using Pearson’s 
correlation coefficient, and between categorical variables using Cramer’s V statistics. For 
comparison between continuous and categorical variables, we calculated point-biserial 
correlation (for a binary variable) or the R-squared of the analysis of variance for categorical 
variables with three or more categories. We decided a priori that if any variables were highly 
correlated (i.e. 0.7 or higher), only one variable would be included in the model. 
We conducted four multilevel, repeated-measures mixed models with three levels (centre, 
participant, and time), with patient and centre entered as random effects. Multilevel analyses 
were selected to account for clustering within centres and patients across several timepoints. We 
used SF-12 PCS, SF-12 MCS, EQ-5D, and WOMAC scores as the dependent variables (one for 
each model). We included all factors specified above as independent variables in fixed effects as 
well as time of HRQL or function assessment (six, 12, and 24 months postoperatively). We 
included preinjury SF-12 PCS, SF-12 MCS, EQ-5D, and WOMAC scores as an adjustment 
variable in the respective models. 
We decided a priori that the SF-12 PCS would be the primary analysis and other questionnaires 
would be secondary (SF-12 MCS, EQ-5D, and WOMAC). We anticipated that the results would 
be similar across the SF-12 PCS, EQ-5D, and WOMAC analyses as they measure similar 
attributes. Overall, we considered factors that remained conserved across the models as being 
more plausible, and those which were inconsistently associated to be less plausible. All tests 
were two-tailed with α = 0.05. A p-value < 0.05 was considered statistically significant. We used 
SAS software, version 9.4 (SAS Institute, Cary, North Carolina) for the statistical analyses. 
 
Results 
 
Baseline characteristics 
A total of 627 patients with a femoral neck fracture met the inclusion criteria for at least one 
model in the analysis. Their mean age was 72.5 years (62.4 to 99.0); most (397, 63.3%) were 
women, were not institutionalized (612, 97.6%), were not current smokers (515, 82.1%), were 
not diabetic (529, 84.4%), had an undisplaced fracture (447, 71.3%), and were treated by closed 
reduction and internal fixation (386, 61.6%) (Table I). 
 
Factors associated with postfracture SF-12 PCS 
A total of 563 patients (89.8%) met the inclusion criteria for the SF-12 PCS model. We found 
that the following factors were associated with significantly lower mean postfracture SF-12 PCS 
(indicating worse HRQL): higher age (-1.42 for every ten-year increase, 95% confidence interval 
(CI) -2.17 to -0.67, p < 0.001), female gender (-1.52 vs male, 95% CI -3.00 to -0.05, p = 0.04), 
higher BMI (-0.69 for every five-point increase, 95% CI -1.36 to -0.02, p = 0.04), ASA class III 
(-3.19 vs class I, 95% CI -5.73 to -0.66, p = 0.01), and displaced fracture (-2.18 compared with 
undisplaced, 95% CI -3.88 to -0.49, p = 0.01) (Table II). Additionally, smokers treated by 
internal fixation using a SHS had a significantly higher postfracture SF-12 PCS than those 
treated with cancellous screws (3.35, 95% CI 0.02 to 6.67, p = 0.048). In former or non-smokers, 
there was no difference in postfracture SF-12 PCS between those treated with cancellous screws 
and those treated with a SHS. None of the statistically significant adjusted mean differences 
reached the MID for the SF-12 PCS. No other factors were found to be significantly associated 
with postfracture SF-12 PCS. 
 
Factors associated with postfracture SF-12 MCS 
A total of 563 patients (89.8%) also met the inclusion criteria for the SF-12 MCS model. We 
found the following factors were associated with a significantly lower mean postfracture SF-12 
MCS (indicating worse HRQL): female gender (-2.10 vs male, 95% CI -3.50 to -0.71, p = 0.03), 
ASA class III (-3.17 vs class I, 95% CI -5.49 to -0.84, p = 0.01), and displaced fracture (-1.80 vs 
undisplaced, 95% CI -3.39 to -0.21, p = 0.02) (Table III). None of the statistically significant 
adjusted mean differences reached the MID for the SF-12 MCS. No other factors were found to 
be significantly associated with postfracture SF-12 MCS. 
 
Factors associated with post-fracture WOMAC score 
A total of 604 patients (96.3%) met the inclusion criteria for the WOMAC model. We found that 
a displaced fracture (compared with undisplaced) was associated with a significantly higher 
mean postfracture WOMAC score, indicating worse function (3.77, 95% CI 0.73 to 6.81, p = 
0.02) (Table IV). This difference was clinically significant. No other factors were found to be 
significantly associated with the WOMAC score. 
 
Factors associated with EQ-5D score 
A total of 581 patients (92.6%) met the inclusion criteria for the EQ-5D model. We found that 
the following factors were associated with significantly lower mean postfracture EQ-5D scores, 
indicating worse health utility: higher age (-0.01 for every ten-year increase, 95% CI -0.02 to -
0.002, p = 0.02), female gender (-0.04 vs male, 95% CI -0.06 to -0.02, p < 0.001), higher BMI (-
0.02 for every five-point increase, 95% CI -0.03 to -0.01, p < 0.001), ASA class II 
(-0.03 vs class I, 95% CI -0.05 to -0.001, p = 0.04), ASA class III (-0.07 vs class I, 95% CI -0.11 
to -0.04, p < 0.001), ASA class IV (-0.10 vs class I, 95% CI -0.17 to -0.04, p = 0.002), a 
displaced fracture (-0.05 vs undisplaced, 95% CI -0.07 to -0.03, p < 0.001), and closed reduction 
(-0.03 vs no reduction, 95% CI -0.05 to -0.01, p = 0.01) (Table V). Only the adjusted mean 
differences for ASA class III and IV, compared with class I were clinically significant. No other 
factors were found to be significantly associated with EQ-5D scores. 
 
 
Discussion 
 
We found that sustaining a displaced femoral neck fracture, compared with an undisplaced 
fracture, was significantly associated with lower postfracture HRQL, hip function, and health 
utility scores across all four measures. Additionally, we found that female gender and ASA class 
III (compared with class I) were significantly associated with lower postfracture SF-12 PCS, SF-
12 MCS, and EQ-5D scores, and that older age and higher BMI were significantly associated 
with lower postfracture SF-12 PCS and EQ-5D scores. Finally, we found that ASA class II and 
IV (compared with class I) and closed reduction (compared with no reduction) were significantly 
associated with lower postfracture EQ-5D scores. 
These findings must be interpreted with caution as only the association between a displaced 
fracture and higher WOMAC scores was clinically significant. Tidermark et al14 also reported 
an association between a displaced femoral neck fracture and lower postfracture HRQL in a 
prospective study. In a study including 90 elderly patients with a fracture of the femoral neck, 
they found that HRQL, as measured by the EQ-5D, was significantly lower in those with a 
displaced fracture that healed uneventfully compared with those with an undisplaced fracture that 
healed uneventfully, 26 months postoperatively. This difference surpassed the MID reported for 
the EQ-5D.20 However, a smaller prospective study of 45 patients, including 24 with a femoral 
neck fracture and 21 with a trochanteric fracture, reported no significant differences in HRQL, as 
measured by the 36-item Short Form Health Survey (SF-36), between those with displaced and 
undisplaced fractures, four months postfracture.25 This discrepancy may be explained by the 
small sample size, short follow-up, and inclusion of patients with trochanteric fractures in the 
latter study.25 To the best of our knowledge, no studies to date have looked at the association 
between gender or ASA classification and HRQL, hip function, and health utility specifically in 
patients who have sustained a femoral neck fracture. However, a systematic review examining 
factors associated with HRQL in many types of hip fractures concluded that there was strong 
evidence that female gender was associated with lower HRQL scores.9 ASA class was not 
included as an outcome in this review. However, the authors reported strong evidence that 
comorbidity was negatively associated with HRQL which may relate to ASA classification as 
comorbidities can increase the ASA class.26 
The importance of including patient specific outcomes, such as HRQL, hip function, and health 
utility, in clinical trials is being increasingly recognized.27 However, when looking at these 
outcomes, it is important to assess whether statistically significant results are also clinically 
significant.28 While a number of statistically significant predictors of HRQL, function, and 
health utility were identified in our study, few were clinically significant. Specifically, only the 
adjusted mean difference for a displaced fracture in the WOMAC model, and ASA class III and 
IV (compared with class I) in the EQ-5D model, were found to be clinically significant. Our 
findings show that while a number of factors may be associated with small changes in HRQL, 
function and health utility, few are associated with any meaningful differences in these outcomes 
for patients. This may suggest a need for clinicians and researchers to explore adjuvant therapies 
or psychosocial interventions, to help improve the HRQL, function, and health utility of patients 
following a femoral neck fracture. 
This study has several methodological strengths. To the best of our knowledge, it is the first to 
focus on several factors associated with HRQL, hip function, and health utility in a large 
prospective cohort of patients with a femoral neck fracture. The large sample size and 
prospective collection of data contribute to the validity of the results, as does the inclusion of 
four different outcome measures. Additionally, data were collected from 65 centres in five 
countries (Canada, The United States, The Netherlands, Norway, and Australia), which increases 
the applicability of the findings. The study is also strengthened by the 24-month follow-up 
period, which allows a long-term assessment of the patients, as well as the multilevel mixed 
model analysis, which accounts for changes in HRQL, hip function, and health utility over time 
and minimizes the impact of confounding variables. Despite these strengths, the study is limited 
in the context of its design. Due to the use of a nonrandomized design, it is only possible to 
conclude that an association exists between factors and HRQL, hip function, and health utility, 
but not the causation of these relationships. Therefore, recommendations based on these results 
must be interpreted within the context of the design of the study and further research should be 
conducted to determine if interventions to alter any of the associated factors will result in 
improved HRQL, hip function, and health utility for these patients. Additionally, our study 
included 627 patients, 59% of the those in the FAITH trial. The lower number of patients is 
because the FAITH trial collected HRQL, hip function, and health utility data from a subset of 
patients. The collection of these data ceased after the estimated sample size required for 
secondary HRQL comparisons between the treatment groups were met. Furthermore, our 
analysis excluded patients who did not have complete data for all factors and respective baseline 
HRQL, hip function, and health utility measures. Despite this, the study is one of the largest to 
investigate variables associated with HRQL, hip function, and health utility in patients with a 
fracture of the femoral neck. 
In conclusion, we identified several baseline factors that are associated with lower postfracture 
HRQL, hip function, and health utility (older age; higher BMI; female gender; ASA class II, III, 
and IV (compared with class I); a displaced fracture; closed reduction (compared with no 
reduction); and cancellous screw fixation in current smokers. Aside from a displaced fracture, 
closed reduction (compared with no reduction) and cancellous screw fixation in current smokers, 
we did not find any fracture or surgical characteristics that were associated with lower HRQL 
scores. These findings may be used to provide patients with more information about their injury 
and expected outcomes at two years, as well as possibly to guide care. 
 
Supplemental material 
A full list of the FAITH Investigators is available alongside the online version of this article at 
www.bjj.boneandjoint.org.uk 
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